EDGAR Filing Documents for 0000950135-09-004070

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0000950135-09-004070

Filing Date

2009-05-15

Accepted

2009-05-15 16:44:59

Documents

Period of Report

2009-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	RXI PHARMACEUTICALS CORPORATION	b75227rxe10vq.htm	10-Q	150932
2	EX-10.1 LEASE AMENDMENT DATED MARCH 5, 2009	b75227rxexv10w1.htm	EX-10.1	4593
3	EX-31.1 SARBANES-OXLEY ACT SECTION 302 CERTIFICATION OF TOD WOOLF	b75227rxexv31w1.htm	EX-31.1	8244
4	EX-31.2 SARBANES-OXLEY ACT SECTION 302 CERTIFICATION OF STEPHEN J. DIPALMA	b75227rxexv31w2.htm	EX-31.2	8529
5	EX-32.1 SARBANES-OXLEY ACT SECTION 906 CERTIFICATION OF TOD WOOLF AND STEPHEN J.	b75227rxexv32w1.htm	EX-32.1	4732
	Complete submission text file	0000950135-09-004070.txt		178360

Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605

Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861

RXI PHARMACEUTICALS CORP (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 09833926
SIC: 2834 Pharmaceutical Preparations